Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig.7.B
Gur M et al. (2022)
|
Xla Wt + aldh1a2 CRISPR
NF10.25 (RT-PCR)
|
|
|
|
Fig.3.A-G
Gur M et al. (2022)
|
Xla Wt + DEAB
NF10.25 (RT-PCR)
|
|
|
|
Fig.3.H
Gur M et al. (2022)
|
Xla Wt + DEAB
NF10.25 (RT-PCR)
|
|
|
|
Fig.3.A-G
Gur M et al. (2022)
|
Xla Wt + Retinoic acid
NF10.25 (RT-PCR)
|
|
|
|
Fig.5.Col.5
Mukherjee S et al. (2020)
|
Xtr Wt + ctnnb1 MO
NF10.5 (in situ hybridization)
|
|
|
|
Fig.5.Col.2
Mukherjee S et al. (2020)
|
Xtr Wt + sox17a MO + sox17b.1/b.2 MO
NF10.5 (in situ hybridization)
|
|
|
|
Fig. 7 A row 1 col 2
Jalvy S et al. (2019)
|
Xla Wt + lif
NF 12.5 (RT-PCR)
|
|
|
|
Fig. 5 e f
Harata A et al. (2019)
|
Xla Wt + p2ry4
NF9 (in situ hybridization)
|
|
|
|
Fig. 4 f
Harata A et al. (2019)
|
Xla Wt + p2ry4 TALEN
NF11 (in situ hybridization)
|
|
|
|
fig.6.f, g
Zhang X et al. (2015)
|
Xla Wt + jmjd6 MO
NF10.5 (in situ hybridization)
|
|
|